Skip to main content
ADHERIUM LIMITED logo

ADHERIUM LIMITED — Investor Relations & Filings

Ticker · ADR ISIN · AU000000ADR1 ASX Manufacturing
Open in API
Filings indexed 878 across all filing types
Latest filing 2018-05-16 Regulatory Filings
Country AU Australia
Listing ASX ADR

About ADHERIUM LIMITED

https://www.adherium.com

Adherium Limited is a digital health company specializing in the development and commercialization of connected medical devices and software solutions for chronic respiratory management. The company's primary offering is the Hailie® platform, which consists of advanced sensors that attach to various inhaler medications to monitor usage and technique. These sensors transmit data via Bluetooth to a mobile application and a cloud-based portal, providing patients and healthcare providers with real-time insights into medication adherence and respiratory health trends. By facilitating remote patient monitoring and data-driven clinical decisions, Adherium aims to improve health outcomes for individuals living with asthma and chronic obstructive pulmonary disease (COPD). The platform is utilized by healthcare systems, pharmaceutical companies, and clinical research organizations to enhance patient engagement and optimize treatment efficacy.

Recent filings

Filing Released Lang Actions
Adherium launches new global brand Hailie 2 pages 171.5KB
Regulatory Filings Classification · 95% confidence The document is a press release announcing the launch of a new global brand (Hailie™) by Adherium, describing the product features, clinical background, and company information. It does not contain financial data, regulatory filings, voting results, or any report-type content. It is a corporate announcement about a product and brand launch, not a financial or regulatory report. Therefore, it does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The closest fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2018-05-16 English
Adherium CEO to present at Chardan Digital Health 2 pages 178.5KB
Investor Presentation Classification · 85% confidence The document is a press release announcing Adherium's participation in the Chardan Digital Health Conference on May 22, 2018. It includes details about the CEO's scheduled presentation and panel participation, as well as background information about the company and contact details for inquiries. There is no financial data, no report attached or referenced as being published, and no regulatory or shareholder meeting content. The document is an investor presentation announcement or event participation notice rather than a full investor presentation document. Given the content and length (2382 characters), it does not qualify as a full Investor Presentation (IP) but rather an announcement related to investor communication. However, since the filing categories do not include a specific category for event participation announcements, the closest appropriate classification is Investor Presentation (IP) because the document focuses on investor-related presentation content and company strategy overview at a conference.
2018-05-15 English
Daily share buy-back notice - Appendix 3E 3 pages 237.3KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and references ASX rules related to share buy-backs. It details the number of shares bought back, the type of buy-back (Employee Share Plan buy-back), and compliance statements. There is no financial performance data, earnings information, or management discussion. The document is a formal notice of share repurchase activity, consistent with a report of the company buying back its own shares. Therefore, it fits the category of 'Transaction in Own Shares' (POS). The document length is short and focused solely on buy-back details, confirming it is not a full financial report or announcement of a report publication.
2018-05-09 English
Final share buy-back notice - Appendix 3F 2 pages 241.2KB
Transaction in Own Shares Classification · 95% confidence The document is titled 'Appendix 3F Final share buy-back notice' and contains detailed information about a share buy-back transaction, including the type of buy-back (Employee Share Plan buy-back), number of shares bought back, consideration paid (none, as it extinguishes a loan), and compliance statements. It is a formal notice related to the company's repurchase of its own shares. The document is relatively short (2189 characters) and focuses specifically on the buy-back event rather than broader financial results or reports. This matches the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares. Therefore, the correct classification is POS with high confidence.
2018-05-09 English
Adherium Investor Conference Call Presentation 12 pages 4.0MB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Investor Results Q3 FY18' and contains detailed financial and operational information for the third quarter ending March 31, 2018. It includes quarterly cash flow data, revenue growth, expenses, shipment volumes, strategic priorities, and guidance for the fiscal year 2018. The content is comprehensive and focused on a specific quarter, with actual financial figures and business analysis. It is not a brief announcement or a presentation for an AGM, nor is it a certification or a regulatory filing. The document fits the definition of an Interim / Quarterly Report (IR), as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q3 2018
2018-05-03 English
Adherium Announces Program with Vitalus Health 2 pages 54.4KB
Regulatory Filings Classification · 95% confidence The document is a press release announcing a new program partnership between Adherium and Vitalus Health related to the launch of a health technology product. It contains no financial data, no regulatory filing references, no voting results, no management or board changes, no earnings or financial reports, and no legal or capital structure updates. It is a corporate announcement about a business development initiative. Therefore, it does not fit into any specific financial or regulatory filing categories such as Annual Report, Earnings Release, or Regulatory Filings. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2018-04-30 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.